rc 3095 has been researched along with sermorelin in 1 studies
| Studies (rc 3095) | Trials (rc 3095) | Recent Studies (post-2010) (rc 3095) | Studies (sermorelin) | Trials (sermorelin) | Recent Studies (post-2010) (sermorelin) |
|---|---|---|---|---|---|
| 108 | 2 | 26 | 305 | 29 | 64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, YF; Wu, B; Xu, Y | 1 |
1 review(s) available for rc 3095 and sermorelin
| Article | Year |
|---|---|
New agonist- and antagonist-based treatment approaches for advanced prostate cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Bombesin; Clinical Trials as Topic; Humans; Leuprolide; Male; Neoplasms, Hormone-Dependent; Octreotide; Oligopeptides; Peptide Fragments; Prostatic Neoplasms; Sermorelin | 2012 |